Catheter-related Bladder Discomfort, Nefopam
Conditions
Brief summary
In the present study, the investigators evaluated whether nefopam 20 mg reduce the catheter-related bladder discomfort in patients undergoing foley catheter insertion
Interventions
DRUGNefopam or saline
One hour before the end of the operation, the Nefopam group was received 20 mg of nefopam and the saline and the control group was received 20 ml of saline.
Sponsors
Seoul National University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
20 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Patients scheduled to insert the catheter a new foley catheter more than 14 Fr in the operation site, 2. Adults 20 to 75years of age 3. American Society of Anesthesiologists Physical Classification 1,2 patients 4. Patients who pre-agreed to the study 5. Male patient
Exclusion criteria
1. Neurogenic bladder 2. Patients diagnosed with irritable bladder 3. study drug sensitive or contraindicated 4. Patients with central nervous system or neurological disorder (epilepsy, patients receiving MAO inhibitor) 5. Patients with urethral and prostate disorders 6. Patients with previous history of myocardial infarction 7. Patients with closed angle glaucoma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| catheter-related bladder discomfort | postoperative 1 hour | assessment of catheter-related bladder discomfort using visual analogue scale |
Countries
South Korea
Outcome results
None listed